COVID-19 vaccine tracker: Over 33.81 lakh jabs administered in India on July 7; total coverage crosses 36.48 crore

India has administered 36,48,47,549 doses of COVID-19 vaccine till July 7.

Moneycontrol News
July 08, 2021 / 09:54 AM IST

On the 173rd day of the vaccination drive on July 7, 33,81,671 vaccine doses were administered.(Representative image: Reuters)

More than 33.81 lakh COVID-19 vaccine doses were administered in India on July 7, the Union Health Ministry's data suggested. With that, the cumulative number of COVID-19 vaccine doses administered in the country crossed 36.48 crore.

On the 173rd day of the vaccination drive on July 7, 33,81,671 vaccine doses were administered.

Uttar Pradesh, Madhya Pradesh, Rajasthan, Tamil Nadu, Bihar, Gujarat, Karnataka and Maharashtra have administered more than 50 lakh first dose of COVID-19 vaccine in the 18-44 years age group.

Also, Andhra Pradesh, Assam, Chhattisgarh, Delhi, Haryana, Jharkhand, Kerala, Telangana, Himachal Pradesh, Odisha, Punjab, Uttarakhand and West Bengal have vaccinated over 10 lakh beneficiaries of the 18-44 years age group for the first dose of Covid vaccine, the ministry said.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Here are key developments related to the COVID-19 vaccination process:

- The Gujarat government has said the COVID-19 vaccination drive will remain suspended in the state for two more days but did not spell out the reason. The state government had halted the anti-coronavirus vaccination on Wednesday due to `Mamata Diwas', a day observed as part of the ongoing universal immunization program for pregnant women, additional chief secretary (health) Manoj Aggarwal had said earlier.

- Only 22,289 COVID-19 vaccine doses were administered in the national capital on July 7, according to data. Delhi received 12,440 doses of Covaxin and 3,07,630 doses of Covishield on July 6. With this, Delhi has two days of vaccine stocks left, according to the vaccination bulletin.

- The Union Territory of Ladakh has administered the first dose of COVID-19 vaccine to its entire eligible population, officials told PTI. The administration has given the first jab of Covid vaccine to the beneficiaries and covered 100 per cent of healthcare workers (HCWs) and frontline workers (FLWs) and 45-plus years and 18-44 years age groups, an official spokesperson said.

- People who receive COVID-19 vaccines by Pfizer and Moderna are up to 91 percent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The research, published in the New England Journal of Medicine on June 30, is among the first to show the benefits of mRNA vaccines even among those who experience breakthrough infections -- testing positive after immunisation.

- Goa has achieved the milestone of administering 10 lakh doses of COVID-19 vaccines in the coastal state, Chief Minister Pramod Sawant has said. In a tweet on Tuesday, the CM said that a total of 10,06,824 doses were administered in the state till July 6. "A milestone achieved! I thank the people of Goa for their overwhelming support, and our Doctors, Nurses and Healthcare workers for their tireless efforts in the vaccination drive," Sawant said in the tweet.

Here's the vaccination count for some states:
StatesTotal Beneficiaries
Andhra Pradesh1,66,76,871
Arunachal Pradesh 6,67,319
Assam77,20,596
Bihar1,76,11,620
Chandigarh5,80,735
Chhattisgarh 1,01,05,253
Delhi 85,20,756
Goa10,36,104
Gujarat2,73,40,028
Haryana96,17,512
Himachal Pradesh41,73,030
Jharkhand75,15,789
Karnataka2,47,39,593
Kerala1,51,20,586
Madhya Pradesh2,24,87,608
Maharashtra3,54,45,024
Odisha1,31,31,821
Punjab 80,91,520
Rajasthan2,59,37,769
Tamil Nadu1,70,94,597
Telangana 1,19,92,902
Uttar Pradesh 3,52,72,000
Uttarakhand 48,01,599
West Bengal2,33,66,803

(With inputs from PTI)

Click here for Moneycontrol’s full coverage of the coronavirus pandemic
Moneycontrol News
Tags: #coronavirus #COVAXIN #Covishield #Current Affairs #Health #India
first published: Jul 8, 2021 09:54 am